Facebook
Linkedin
Tumblr
Twitter
Sign in
My Account
orders
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sign in / Join
Facebook
Linkedin
Tumblr
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Market Exclusive
My Account
orders
Home
Tags
NYSE:AZN
Tag: NYSE:AZN
GlaxoSmithKline PLC (NYSE:GSK) To Accelerate Filing For COPD Combo Treatment
Andy Parker
-
June 9, 2016
0
AstraZeneca plc (NYSE:AZN) Offloads European Commercial Rights To Zurampic To Grünenthal...
Andy Parker
-
June 3, 2016
0
AstraZeneca plc (NYSE:AZN) Received Positive Phase 3 Data Amidst Stiffening Competition...
-
May 24, 2016
0
AstraZeneca plc (NYSE:AZN) Begins $1.1B Cost-Cutting Plan With Sales Reps Cutbacks
Andy Parker
-
May 18, 2016
0
AstraZeneca plc (ADR) (NYSE:AZN) Posts Positive Phase III Trial Results For...
Carol Harper
-
May 17, 2016
2
Pfizer Inc. (NYSE:PFE) Resorts To Little Sock Puppets To Promote Nexium...
Andy Parker
-
May 10, 2016
0
Celgene Corporation (NASDAQ:CELG), Novartis AG (NYSE:NVS) Take Stakes in Flexus Biosciences
-
May 4, 2016
0
AstraZeneca Plc (ADR) (NYSE:AZN) Latest Initiative To House 2 Million Genomes
Andy Parker
-
April 26, 2016
0
FDA Grants Orphan Status To AstraZeneca PLC (ADR) (NYSE:AZN) Neuromyelitis Drug
Carol Harper
-
March 9, 2016
0
AstraZeneca plc (ADR) (NYSE:AZN) Strikes Deal With ProStrakan Group For Moventig...
Carol Harper
-
March 2, 2016
0
1
...
9
10
11
Page 10 of 11